PLSMHealthcare · Medical Devices

PLSM Stock Forecast: Pulsenmore Ltd. Price Predictions for 2026-2027

Last close, 21 Aug 2026

$2.89

+1.76% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 30 of 100 as at 22 Aug 2026 — in the lower half.

Market cap

$18.8M

Ticker Nerd rank

30 / 100

Median analyst target

—

Analysts covering

—

Total return, dividends reinvested

−2.0%

−18.8%

From high

−60.7%

From low

+1.8%

$2.84

$7.36

Range since 21 Jan 2026, adjusted closes · the dot is the last close

Ticker Nerd rank

PLSM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Pulsenmore Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

30 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth

Size

Issuance

Quality

Accruals

Revisions

Momentum

Value

Volatility

Growth (98): Sales and profits are climbing, and climbing faster than before.

Volatility (1): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PLSM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PLSM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, since 21 Jan 2026Adjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PLSM appears on the weeks it earns a place.

Estimates

PLSM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Pulsenmore Ltd. (PLSM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −1.2×
Price / sales: 0.5×
Price / book: —
EV / EBITDA: 0.2×

Growth & margins

Revenue growth (YoY): 578.3%
Earnings growth (YoY): —
Gross margin: —
Operating margin: −38.8%
Net margin: −39.6%

Returns & dividend

Return on equity: −17.6%
Return on assets: −6.2%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

PLSM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices

Company	Market cap	TKN rank
PLSMPulsenmore Ltd.	$18.8M	30
LFWDLifeward Ltd.	$20.6M	21
NMTCNeuroOne Medical Technologies Corp.	$18.5M	49
CTSOCytoSorbents Corp.	$23.2M	47
TELATELA Bio, Inc.	$28.8M	27
MODDModular Medical, Inc.	$28.9M	11
ADGMAdagio Medical Holdings, Inc.	$13.7M	36

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Pulsenmore Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PLSM news & analysis

Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring

PRNewsWire · 19 Aug 2026positive

Pulsenmore announced the expansion of its home ultrasound activity in Israel, with its technology being integrated at the Lis Maternity and Women's Hospital at Ichilov, joining other medical centers that already use it in pregnancy monitoring pathways.

Why it matters — This expands adoption of Pulsenmore's home ultrasound technology at another major Israeli medical center, broadening its footprint in pregnancy monitoring.

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program

PRNewsWire · 17 Aug 2026positive

Pulsenmore received a second AI grant from the Israel Innovation Authority within one month, approving $1.27 million for its SmartScan AI program. Combined with a prior grant, total AI grants approved over the past month amount to approximately $1.6 million, supporting two programs with a combined scope of about $3.12 million aimed at advancing AI-powered home ultrasound.

Why it matters — A PLSM watcher would care because the grants signal continued institutional support and funding for Pulsenmore's AI-driven home ultrasound technology development.

FAQ

Frequently asked questions about PLSM stock

How does Ticker Nerd's model rank PLSM?

As at 22 Aug 2026, Pulsenmore Ltd. ranks 30 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (98 of 100).

What is the PLSM stock forecast for 2030?

No analyst covering Pulsenmore Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PLSM are extrapolating price history, which says nothing about the business.

What does Pulsenmore Ltd. do?

Pulsenmore Ltd. is a healthcare technology company that develops and markets home-use ultrasound and digital health solutions focused primarily on prenatal care.

What is the latest news on PLSM?

The most recent item we track (PRNewsWire, 19 Aug 2026): "Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring". Pulsenmore announced the expansion of its home ultrasound activity in Israel, with its technology being integrated at the Lis Maternity and Women's Hospital at Ichilov, joining other medical centers that already use it in pregnancy monitoring pathways.

Company

About Pulsenmore Ltd.

Pulsenmore Ltd. is a healthcare technology company that develops and markets home-use ultrasound and digital health solutions focused primarily on prenatal care. The company’s core offering is a self-scan ultrasound system that combines a handheld ultrasound cradle that docks with a patient’s smartphone, a dedicated mobile application, and secure cloud infrastructure for image transmission and storage. This setup enables pregnant women to perform guided scans at home, with images and video made available for physician-supervised review and remote clinical assessment. Pulsenmore Ltd. serves the broader telehealth, digital health, and femtech segments by supporting remote monitoring, reducing dependence on in-clinic visits, and integrating with clinician dashboards and workflows. Headquartered in Israel, the company positions its technology as an infrastructure component for healthcare providers and payers seeking to expand remote prenatal services and improve continuity of care within existing medical systems.

CEO Dr. Elazar Sonnenschein · 71 employees · Israel · https://www.pulsenmore.com